0001437749-15-016755.txt : 20150901 0001437749-15-016755.hdr.sgml : 20150901 20150901192342 ACCESSION NUMBER: 0001437749-15-016755 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150831 FILED AS OF DATE: 20150901 DATE AS OF CHANGE: 20150901 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: IMPAX LABORATORIES INC CENTRAL INDEX KEY: 0001003642 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 650403311 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 30831 HUNTWOOD AVENUE CITY: HAYWARD STATE: CA ZIP: 94544 BUSINESS PHONE: 510-240-6000 MAIL ADDRESS: STREET 1: 30831 HUNTWOOD AVENUE CITY: HAYWARD STATE: CA ZIP: 94544 FORMER COMPANY: FORMER CONFORMED NAME: GLOBAL PHARMACEUTICAL CORP \DE\ DATE OF NAME CHANGE: 19951117 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BENET LESLIE Z CENTRAL INDEX KEY: 0001245186 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34263 FILM NUMBER: 151088337 MAIL ADDRESS: STREET 1: UCSF BIOPHARMACEUTICAL SCIENCES STREET 2: 533 PARNASSUS AVENUE, ROOM U68 CITY: SAN FRANCISCO STATE: CA ZIP: 94143 4 1 rdgdoc.xml FORM 4 X0306 4 2015-08-31 0001003642 IMPAX LABORATORIES INC IPXL 0001245186 BENET LESLIE Z C/O IMPAX LABORATORIES, INC. 30831 HUNTWOOD AVENUE HAYWARD CA 94544 1 Common Stock 2015-08-31 4 M 0 3000 18.09 A 12200 D Common Stock 2015-08-31 4 S 0 3000 40.92 D 9200 D Common Stock 2015-08-31 4 M 0 3000 20.47 A 12200 D Common Stock 2015-08-31 4 S 0 3000 40.92 D 9200 D Common Stock 2015-08-31 4 M 0 3000 25.18 A 12200 D Common Stock 2015-08-31 4 S 0 3000 40.92 D 9200 D Common Stock 2015-08-31 4 M 0 3000 23.60 A 12200 D Common Stock 2015-08-31 4 S 0 3000 40.92 D 9200 D Common Stock 2015-08-31 4 M 0 2750 29.03 A 11950 D Common Stock 2015-08-31 4 S 0 2750 40.92 D 9200 D Common Stock 2015-08-31 4 M 0 2750 27.80 A 11950 D Common Stock 2015-08-31 4 S 0 2750 40.92 D 9200 D Common Stock 2015-08-31 4 M 0 2500 6.55 A 11700 D Common Stock 2015-08-31 4 S 0 2500 40.92 D 9200 D Common Stock 600 I By the Benet Family Trust Stock Option (Right to Buy) 18.09 2015-08-31 4 M 0 3000 0 D 2018-06-21 Common Stock 3000 0 D Stock Option (Right to Buy) 20.47 2015-08-31 4 M 0 3000 0 D 2018-10-25 Common Stock 3000 0 D Stock Option (Right to Buy) 25.18 2015-08-31 4 M 0 3000 0 D 2019-01-03 Common Stock 3000 0 D Stock Option (Right to Buy) 23.60 2015-08-31 4 M 0 3000 0 D 2019-04-04 Common Stock 3000 0 D Stock Option (Right to Buy) 29.03 2015-08-31 4 M 0 2750 0 D 2019-07-11 Common Stock 2750 0 D Stock Option (Right to Buy) 27.80 2015-08-31 4 M 0 2750 0 D 2019-10-24 Common Stock 2750 0 D Stock Option (Right to Buy) 6.55 2015-08-31 4 M 0 2500 0 D 2019-05-20 Common Stock 2500 53500 D The price reported in Column 4 is a weighted average price. These shares were sold at prices ranging from $40.37 to $41.87 in multiple transactions. The reporting person undertakes to provide to Impax Laboratories, Inc., any security holder of Impax Laboratories, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4. 100% of the shares subject to the option are fully vested and exercisable. The filing of this Statement shall not be construed as an admission (a) that the person filing this Statement is, for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended, the beneficial owner of any equity securities covered by this Statement, or (b) that this Statement is legally required to be filed by such person. /s/ Mark A. Schlossberg, by Power of Attorney 2015-09-01